PRE-MARKET INDIAN STOCKS NEWS: ICICI Lombard General Insurance Company (ICICIGI IS) Q4 profit rose 7.25% Y/Y to INR 5.47bln (prev. INR 5.10bln), gross premium written rose 16.94% Y/Y to INR 80.74bln (prev. INR 69.04bln), net premium earned rose 10.8
Aurobindo Pharma (ARBP IS) - Co.’s subsidiary TheraNym Biologics expanded its existing CMO agreement with Merck Sharp & Dohme Singapore Trading through execution of an additional product schedule. (Moneycontrol)
GMR Airports (GMRAIR IS) - Co. Q4 passenger traffic rose 0.9% Y/Y to 3.18 crore, domestic traffic rose 1.6% Y/Y to 2.41 crore, international traffic fell 1.3% Y/Y to 0.77 crore, aircraft movements rose 1.9% Y/Y to 1.92 lakh. (Moneycontrol)
HDB Financial Services (HDBFS IS) - Co. Q4 profit rose 41.4% Y/Y to INR 7.51bln (prev. INR 5.31bln), net interest income rose 21.6% Y/Y to INR 23.99bln (prev. INR 19.73bln). (Moneycontrol)
ICICI Lombard General Insurance Company (ICICIGI IS) - Co. Q4 profit rose 7.25% Y/Y to INR 5.47bln (prev. INR 5.10bln), gross premium written rose 16.94% Y/Y to INR 80.74bln (prev. INR 69.04bln), net premium earned rose 10.8% Y/Y to INR 57.91bln (prev. INR 52.26bln), operating profit rose 31.2% Y/Y to INR 5.46bln (prev. INR 4.16bln). (Moneycontrol)
ICICI Lombard's Q4 results show a solid 7.25% increase in profit year-over-year, driven by a 16.94% rise in gross premiums written. This performance reflects strong demand in the insurance sector and suggests a favorable outlook for future revenues, which could indicate further growth potential in a competitive market. Analysts might view these results positively, supporting a strong position in the insurance space amidst broader economic conditions.